Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse.
Please provide your email address to receive an email when new articles are posted on . The patient — a man in his mid-60s with advanced cancer — had been in severe pain despite being on a high dose ...
Two years ago, Emma Dimery was told her stage 4 colon cancer was incurable. Today, she is healthy and cancer-free — and she says a last-resort clinical trial saved her life. Dimery, who lives in ...
Morning Overview on MSN
Two new pancreatic cancer treatments — a targeted pill and a personalized mRNA vaccine — are beating back one of medicine’s deadliest tumors in early trials
Pancreatic cancer has long been oncology’s most stubborn adversary. Fewer than 13% of patients survive five years after ...
Kelly Spill didn’t cry when she was diagnosed with stage III rectal cancer at age 28. She held her emotions together when her surgeon told her that she might not be able to carry another baby — ...
For men with advanced prostate cancer that no longer responds to standard hormone therapies, treatment options are ...
US cancer centers are grappling with an influx of patient requests for an experimental pancreatic cancer drug, daraxonrasib, ...
Cancer is the second leading cause of death within the US. The sooner it is detected through screening, the sooner it can be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results